person · Reporting owner
ANDERSON RICHARD ALAN
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DarioHealth Corp.DRIO · Entity 7024 | President | March 06, 2024 | March 08, 2024 |
| Ontrak, Inc.CATS · Entity 78207 | Director · President & COO | August 02, 2018 | August 03, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DarioHealth Corp.
Report date March 06, 2024 · Filed March 08, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.68 | Direct | 750,000 |
Reported balance
After 2024-03-06 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-03-06 · Grant · Acquired 750,000 · Balance 750,000 F1: The options will vest over a two-year period commencing on the grant date, with 50% vesting on the grant date and 50% vesting in eight equal quarterly installments following the grant date, subject to the employee's continued employment by the Company. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.68 | Direct | 320,000 |
Reported balance
After 2024-03-06 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-03-06 · Grant · Acquired 320,000 · Balance 320,000 F2: The option will vest upon reaching certain performance milestones between December 31, 2024 and March 31, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: The options will vest over a two-year period commencing on the grant date, with 50% vesting on the grant date and 50% vesting in eight equal quarterly installments following the grant date, subject to the employee's continued employment by the Company.
F2: The option will vest upon reaching certain performance milestones between December 31, 2024 and March 31, 2025.
Ontrak, Inc.
Report date August 02, 2018 · Filed August 03, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option to purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $7.50 · Expires 2018-08-02 | Direct | 397,693 |
Reported balance
After 2018-08-02 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-08-02 · Grant · Acquired 397,693 · Balance 397,693 F1: These options were granted to Mr. Anderson for his services as the President and Chief Operating Officer of the Company. F2: These options shall vest in five equal tranches, each of which will vest only upon the satisfaction of performance targets established by the Board of Directors and certified as having been met by the Compensation Committee for fiscal years 2018 through 2022, respectively. |
Filing footnotes · ownership attribution and instrument terms
F1: These options were granted to Mr. Anderson for his services as the President and Chief Operating Officer of the Company.
F2: These options shall vest in five equal tranches, each of which will vest only upon the satisfaction of performance targets established by the Board of Directors and certified as having been met by the Compensation Committee for fiscal years 2018 through 2022, respectively.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 06, 2024 Filed Mar 8, 2024 16:22 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantStock Option (right to buy) · Derivative | 320,000 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001104659-24-032413 · tm248350-7_4seq1.xml · derivative · entry 2 ANDERSON RICHARD ALAN · CIK 0001266647 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 320,000 Underlying: Common Stock · 320,000 shares Expires not disclosed F2 · derivative.exercise_date: The option will vest upon reaching certain performance milestones between December 31, 2024 and March 31, 2025. F2 · derivative.expiration_date: The option will vest upon reaching certain performance milestones between December 31, 2024 and March 31, 2025. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 16:22 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantStock Option (right to buy) · Derivative | 750,000 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001104659-24-032413 · tm248350-7_4seq1.xml · derivative · entry 1 ANDERSON RICHARD ALAN · CIK 0001266647 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 750,000 Underlying: Common Stock · 750,000 shares Expires not disclosed F1 · derivative.exercise_date: The options will vest over a two-year period commencing on the grant date, with 50% vesting on the grant date and 50% vesting in eight equal quarterly installments following the grant date, subject to the employee's continued employment by the Company. F1 · derivative.expiration_date: The options will vest over a two-year period commencing on the grant date, with 50% vesting on the grant date and 50% vesting in eight equal quarterly installments following the grant date, subject to the employee's continued employment by the Company. Read SEC document |
| June 09, 2022 Filed Jun 10, 2022 19:00 UTC | DarioHealth Corp. DRIO · Entity 7024 | Disposition to issuerCommon Stock | 17,957 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-22-070253 · tm2218130-1_4seq1.xml · nonDerivative · entry 1 ANDERSON RICHARD ALAN · CIK 0001266647 · President, GM of North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,877 F1 · kind: The reported securities were redeemed by the issuer for aggregate proceeds of $170,275, to satisfy certain withholding tax obligations of existing vested restricted stock awards. The redemption of the securities was approved by the Compensation Committee of the issuer and was exempt pursuant to Rule 16b-3. F1 · price: The reported securities were redeemed by the issuer for aggregate proceeds of $170,275, to satisfy certain withholding tax obligations of existing vested restricted stock awards. The redemption of the securities was approved by the Compensation Committee of the issuer and was exempt pursuant to Rule 16b-3. Read SEC document |
| May 18, 2022 Filed May 20, 2022 17:03 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantStock Option (right to buy) · Derivative | 135,000 | $0.00 Strike: $7.19 | $0.00 |
DisclosureSEC source: 0001104659-22-063452 · tm2216123-7_4seq1.xml · derivative · entry 1 ANDERSON RICHARD ALLAN · CIK 0001266647 · President, GM of North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,000 Underlying: Common Stock · 135,000 shares Expires 2032-05-18 F1 · derivative.exercise_date: The options vest over three years in 12 equal quarterly installments following the grant date, subject to the Reporting Person's continued services to the Issuer. Read SEC document |
| July 18, 2021 Filed Jul 20, 2021 16:31 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantRestricted Stock Units | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-093987 · tm2122591-3_4seq1.xml · nonDerivative · entry 1 ANDERSON RICHARD ALLAN · CIK 0001266647 · President, GM of North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,834 F1 · security: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2 · date: The shares will vest in twelve equal quarterly installments over a three-year period commencing on the date of grant, subject to the Reporting Person's continued employment by the Issuer. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 16:08 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantStock Option (right to buy) · Derivative | 91,652 | $0.00 Strike: $17.89 | $0.00 |
DisclosureSEC source: 0001104659-21-006296 · tm213677-7_4seq1.xml · derivative · entry 2 ANDERSON RICHARD ALLAN · CIK 0001266647 · President, GM of North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,652 Underlying: Common Stock · 91,652 shares Expires 2027-01-19 F2 · derivative.exercise_date: The options will vest in twelve equal quarterly installments over a three-year period commencing on January 19, 2021, subject to the Reporting Person's continued employment by the Issuer. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 16:08 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantRestricted Stock Grants | 91,652 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-006296 · tm213677-7_4seq1.xml · nonDerivative · entry 1 ANDERSON RICHARD ALLAN · CIK 0001266647 · President, GM of North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,834 F1 · date: The shares vest over three years as follows: 8.333% shall vest on March 31, 2021, and the remaining shares vest in 11 equal instalments every 3 months thereafter. Read SEC document |
| January 19, 2021 Filed Mar 31, 2021 16:12 UTC Amendment | DarioHealth Corp. DRIO · Entity 7024 | GrantStock Option (right to buy) · Derivative | 91,652 | $0.00 Strike: $17.89 | $0.00 |
DisclosureSEC source: 0001104659-21-044752 · tm2111379d4_4a.xml · derivative · entry 2 ANDERSON RICHARD ALLAN · CIK 0001266647 · President, GM of North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,652 Underlying: Common Stock · 91,652 shares Expires 2027-01-19 F3 · derivative.exercise_date: The options will vest in twelve equal quarterly installments over a three-year period commencing on January 19, 2021, subject to the Reporting Person's continued employment by the Issuer. Read SEC document |
| January 19, 2021 Filed Mar 31, 2021 16:12 UTC Amendment | DarioHealth Corp. DRIO · Entity 7024 | GrantRestricted Stock Units | 91,652 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-044752 · tm2111379d4_4a.xml · nonDerivative · entry 1 ANDERSON RICHARD ALLAN · CIK 0001266647 · President, GM of North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,834 F1 · security: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2 · date: The shares vest over three years as follows: one third of the shares vest on each annual anniversary date of the date of grant; provided, however that the shares shall vest on a pro rata basis on the date the Reporting Person's continuous service to the Issuer ceases. The shares shall immediately vest in the event of a change of control that occurs prior to, or within, 60 days of the termination of the Reporting Person's employment or retention with the Issuer. Read SEC document |
| October 16, 2020 Filed Oct 20, 2020 16:07 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon Stock | 5,182 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-116424 · tm2033754d1_4.xml · nonDerivative · entry 1 ANDERSON RICHARD ALLAN · CIK 0001266647 · President, GM of North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,182 F1 · shares: The reporting person was awarded such securities in exchange for waiving compensation owed between April 2020 and July 2020. Read SEC document |
| September 08, 2020 Filed Sep 10, 2020 16:06 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-103941 · tm2030511d2_4.xml · nonDerivative · entry 1 ANDERSON RICHARD ALLAN · CIK 0001266647 · President, GM of North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 F1 · shares: The reporting person was awarded such securities under the Issuer's Amended and Restated 2012 Equity Incentive Plan. Read SEC document |
| January 30, 2020 Filed Jan 31, 2020 17:00 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantEmployee Stock Option (right to buy) · Derivative | 90,000 | Not disclosed Strike: $8.41 | Not disclosed |
DisclosureSEC source: 0001104659-20-009340 · tm206305d1_4.xml · derivative · entry 2 ANDERSON RICHARD ALLAN · CIK 0001266647 · President, GM of North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires not disclosed F2 · date: The option vests over a three years period commencing on the first day of the relevant following fiscal year, in twelve (12) equal quarterly installments, upon the Company's attainment for each fiscal year ending December 31, 2020 through December 31, 2023, of specified business to business revenues recognized by the Company in the United States, subject in each case to the Reporting Person's continued employment by the company on the applicable vesting date. F2 · price: The option vests over a three years period commencing on the first day of the relevant following fiscal year, in twelve (12) equal quarterly installments, upon the Company's attainment for each fiscal year ending December 31, 2020 through December 31, 2023, of specified business to business revenues recognized by the Company in the United States, subject in each case to the Reporting Person's continued employment by the company on the applicable vesting date. F2 · derivative.exercise_date: The option vests over a three years period commencing on the first day of the relevant following fiscal year, in twelve (12) equal quarterly installments, upon the Company's attainment for each fiscal year ending December 31, 2020 through December 31, 2023, of specified business to business revenues recognized by the Company in the United States, subject in each case to the Reporting Person's continued employment by the company on the applicable vesting date. F2 · derivative.expiration_date: The option vests over a three years period commencing on the first day of the relevant following fiscal year, in twelve (12) equal quarterly installments, upon the Company's attainment for each fiscal year ending December 31, 2020 through December 31, 2023, of specified business to business revenues recognized by the Company in the United States, subject in each case to the Reporting Person's continued employment by the company on the applicable vesting date. Read SEC document |
| January 30, 2020 Filed Jan 31, 2020 17:00 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantEmployee Stock Option (right to buy) · Derivative | 90,000 | Not disclosed Strike: $8.41 | Not disclosed |
DisclosureSEC source: 0001104659-20-009340 · tm206305d1_4.xml · derivative · entry 1 ANDERSON RICHARD ALLAN · CIK 0001266647 · President, GM of North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2026-01-30 F1 · price: The option was granted on January 30, 2020 and provides for vesting as follows: (i) 30,000 shares of common stock vest on first anniversary of the date of grant; and (ii) 60,000 shares of common stock vest in equal quarterly installment during the two year period following the first anniversary of the date of grant, subject to the Reporting Person's continued employment by the company. F1 · derivative.exercise_date: The option was granted on January 30, 2020 and provides for vesting as follows: (i) 30,000 shares of common stock vest on first anniversary of the date of grant; and (ii) 60,000 shares of common stock vest in equal quarterly installment during the two year period following the first anniversary of the date of grant, subject to the Reporting Person's continued employment by the company. Read SEC document |
| January 21, 2020 Filed Jan 22, 2020 16:10 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantEmployee Stock Option (right to buy) · Derivative | 25,000 | Not disclosed Strike: $8.27 | Not disclosed |
DisclosureSEC source: 0001104659-20-005922 · tm205495d1_4.xml · derivative · entry 1 ANDERSON RICHARD ALLAN · CIK 0001266647 · President, GM of North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2026-01-21 F1 · price: The option was granted on January 21, 2020 and provides for vesting as follows: (i) 8,333 shares of common stock vest on first anniversary of the date of grant; and (ii) the balance will vest in eight equal quarterly installments following the first anniversary of the grant date, subject to the Reporting Person's continued employment by the company. F1 · derivative.exercise_date: The option was granted on January 21, 2020 and provides for vesting as follows: (i) 8,333 shares of common stock vest on first anniversary of the date of grant; and (ii) the balance will vest in eight equal quarterly installments following the first anniversary of the grant date, subject to the Reporting Person's continued employment by the company. Read SEC document |
| August 02, 2018 Filed Aug 3, 2018 21:42 UTC | Ontrak, Inc. CATS · Entity 78207 | GrantStock Option to purchase Common Stock · Derivative | 397,693 | Not disclosed Strike: $7.50 | Not disclosed |
DisclosureSEC source: 0001437749-18-014472 · rdgdoc.xml · derivative · entry 1 ANDERSON RICHARD ALLAN · CIK 0001266647 · Director · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 397,693 Underlying: Common Stock · 397,693 shares Expires 2018-08-02 F1 · kind: These options were granted to Mr. Anderson for his services as the President and Chief Operating Officer of the Company. F1 · price: These options were granted to Mr. Anderson for his services as the President and Chief Operating Officer of the Company. F2 · derivative.exercise_date: These options shall vest in five equal tranches, each of which will vest only upon the satisfaction of performance targets established by the Board of Directors and certified as having been met by the Compensation Committee for fiscal years 2018 through 2022, respectively. Read SEC document |
| April 10, 2018 Filed Apr 25, 2018 20:33 UTC | Ontrak, Inc. CATS · Entity 78207 | GrantStock Option to purchase Common Stock · Derivative | 642,307 | Not disclosed Strike: $7.50 | Not disclosed |
DisclosureSEC source: 0001437749-18-007728 · rdgdoc.xml · derivative · entry 1 ANDERSON RICHARD ALLAN · CIK 0001266647 · Director · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 642,307 Underlying: Common Stock · 642,307 shares Expires 2028-04-10 F1 · kind: These options were granted to Mr. Anderson for his services as the President and Chief Operating Officer of the Company. F1 · price: These options were granted to Mr. Anderson for his services as the President and Chief Operating Officer of the Company. F2 · derivative.exercise_date: These options shall vest in five equal tranches, each of which will vest only upon the satisfaction of performance targets established by the Board of Directors and certified as having been met by the Compensation Committee for fiscal years 2018 through 2022, respectively. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.